Genesco Inc.
GCO · NYSE
$0.51 today
- Mkt cap $432.02M
- P/E 21.0
- Day $38.12 – $39.50
Confidence
High conviction
The read
Genesco Q1 2027 shows 3% revenue growth led by Journeys; Schuh sales decline weighs on results
Genesco reported Q1 2027 revenue growth of 3% driven by Journeys' 5% comparable sales and 21 new stores, while Schuh sales declined 9% due to fewer promotions. The mixed brand performance creates uncertainty ahead of June 3 earnings.
Confidence note: Analysis based on partial data with no reported EPS; clear operational trends but earnings and margin details pending June 3.
What happened
Earnings print
Guidance
Price reaction
Street narrative
So what
What changed
What the market is pricing
Fundamental takeaway
Next 30–90 days
Sustained Journeys growth and stabilization or rebound in Schuh sales drive margin expansion and EPS upside.
- boltJune 3 earnings show EPS above -2.55 estimate
- boltSchuh comparable sales improve sequentially
Journeys growth offsets Schuh weakness with flat overall revenue and stable margins, resulting in in-line earnings.
- boltJune 3 earnings meet EPS estimate around -2.55
- boltJourneys maintains low single-digit comp sales growth
Continued Schuh sales weakness pressures margins and earnings, leading to EPS misses and negative sentiment.
- boltJune 3 earnings EPS below -2.55 estimate
- boltSchuh sales decline accelerates beyond 9%
What to do
If you hold it
If you're watching
Keep on your radar
- June 3 Q1 2027 EPS relative to -2.55 estimate
- Schuh comparable sales trends post-April 30
- Gross margin changes reported on June 3
- Journeys store openings and comp sales updates